Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50376238 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_475725 (CHEMBL934611) | ||
| IC50 | 6±n/a nM | ||
| Citation |  Das, J; Moquin, RV; Pitt, S; Zhang, R; Shen, DR; McIntyre, KW; Gillooly, K; Doweyko, AM; Sack, JS; Zhang, H; Kiefer, SE; Kish, K; McKinnon, M; Barrish, JC; Dodd, JH; Schieven, GL; Leftheris, K Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors. Bioorg Med Chem Lett18:2652-7 (2008) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50376238 | |||
| n/a | |||
| Name | BDBM50376238 | ||
| Synonyms: | CHEMBL260134 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C20H16Cl2N6O | ||
| Mol. Mass. | 427.287 | ||
| SMILES | CNC(=O)c1ccc(C)c(Nc2ncnc3n(ncc23)-c2c(Cl)cccc2Cl)c1 |(3.44,3.45,;2.11,4.22,;.78,3.44,;.78,1.91,;-.56,4.21,;-.56,5.76,;-1.9,6.53,;-3.23,5.76,;-4.56,6.53,;-3.23,4.21,;-4.56,3.44,;-4.57,1.9,;-3.24,1.14,;-3.23,-.39,;-4.57,-1.17,;-5.91,-.4,;-7.37,-.87,;-8.28,.37,;-7.37,1.62,;-5.91,1.14,;-8.15,-2.2,;-9.69,-2.18,;-10.45,-.84,;-10.47,-3.5,;-9.72,-4.84,;-8.17,-4.85,;-7.4,-3.53,;-5.86,-3.54,;-1.9,3.44,)| | ||
| Structure | 
| ||